Green Thumb Industries stock analysis
Green Thumb Industries (GTBIF) Stock Price & Analysis
GTBIF Stock Chart & Stats
- Day’s Range
- $5.80 - $6.02
- 52-Week Range
- $5.29 - $10.43
- Previous Close
- $5.95
- Volume
- N/A
- Average Volume (3M)
- 471.64K
- Market Cap
- $1.31B
- Enterprise Value
- $2.39B
- Total Cash (Recent Filing)
- $316.00M
- Total Debt (Recent Filing)
- $554.50M
- Price to Earnings (P/E)
- 14.1
- Beta
- 0.64
- Next Earnings
- Mar 03, 2027 (Est.)
- EPS Estimate
- 0.07
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
Bulls Say, Bears Say
Bulls Say
Revenue And Retail Growth
Broad-based revenue growth across retail and wholesale indicates continued consumer demand and market expansion. Positive same-store sales, alongside growth in multiple states, supports the durability of the platform and provides a foundation for further operating leverage as newer stores mature.
Brands And Market Leadership
Leading branded products and number-one positions in important markets can strengthen customer loyalty, retailer acceptance, and pricing power over time. This competitive positioning also helps GTI monetize both its owned stores and wholesale channel as regulated cannabis markets develop.
Cash Generation And Liquidity
Meaningful operating and free cash flow, supported by substantial cash liquidity, gives GTI flexibility to fund store openings, cultivation and manufacturing investments, and other growth opportunities internally. Manageable leverage further supports resilience and selective capital allocation.
Bears Say
Pricing And Margin Pressure
Persistent price compression and increased competition can reduce the profitability of otherwise healthy revenue growth. Lower gross margins may limit operating leverage, make expansion more costly, and require continued discipline in assortment, production, and retail execution across state markets.
Federal Regulation And Tax Uncertainty
Uncertainty over federal scheduling and tax treatment complicates long-term planning, capital allocation, and the company’s ability to estimate normalized earnings. Continued 280E exposure could also divert cash from expansion or shareholder returns and preserve a structural disadvantage versus other consumer businesses.
Uneven Profitability And Cash Consistency
Although adjusted operating performance and cash generation remain positive, the reported loss and uneven free-cash-flow history show that profitability is not yet consistently translating into shareholder earnings. Ongoing reinvestment, cost growth, and market pressure could keep returns below the platform’s operating potential.
Green Thumb Industries News
GTBIF FAQ
What was Green Thumb Industries’s price range in the past 12 months?
What is Green Thumb Industries’s market cap?
When is Green Thumb Industries’s upcoming earnings report date?
How were Green Thumb Industries’s earnings last quarter?
Is Green Thumb Industries overvalued?
Does Green Thumb Industries pay dividends?
What is Green Thumb Industries’s EPS estimate?
How many shares outstanding does Green Thumb Industries have?
What happened to Green Thumb Industries’s price movement after its last earnings report?
Which hedge fund is a major shareholder of Green Thumb Industries?
What is the TipRanks Smart Score and how is it calculated?
Green Thumb Industries Stock Smart Score
Company Description
Green Thumb Industries
Green Thumb Industries Inc. is a U.S.-based company focused on the cultivation, processing, and distribution of cannabis products for both medicinal and adult recreational consumption. Its diverse product portfolio includes raw cannabis flower and a wide array of manufactured and pre-packaged offerings such as pre-rolls, concentrates, vaporizers, tinctures, edibles, and topicals. These are marketed under well-known brand names including Beboe, Dogwalkers, Doctor Solomon's, Good Green, incredibles, and RHYTHM. The company employs a dual distribution strategy, supplying its products primarily to third-party retail outlets while also engaging in direct-to-consumer sales through its owned and operated dispensaries. Established in 2014, the firm maintains its corporate headquarters in Chicago, Illinois.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Benjamin Kovler
- Employees
- 5,000
- Website
- www.gtigrows.com
- Address
- 325 West Huron Street, Chicago, IL, 60654, US
Green Thumb Industries (GTBIF) Earnings & Revenues
GTBIF Earnings Call
Earnings Call SentimentPositive
The call was predominantly positive: Green Thumb delivered double-digit revenue growth, positive same-store sales, higher normalized EBITDA, strong operating cash flow, brand leadership, and continued expansion supported by a substantial cash balance. However, management emphasized persistent pricing pressure, a stressed consumer, lower reported gross margin, higher operating costs, a GAAP net loss, uncertain federal and hemp policy, and possible continued tax liabilities. The positive operating performance and strategic positioning outweighed the stated challenges.
View all GTBIF earnings summariesTechnical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 6 | 1 | 15 |
| Technical Analysis | 6 | 1 | 3 |
| Moving Averages | 0 | 0 | 12 |











